Integrated Safety Analysis of Tagraxofusp, a CD123-Directed Targeted Therapy, in Patients with Hematologic Malignancies

Pemmaraju, N., Kantarjian, H., Sweet, K., Wang, E. S., Lane, A. A., Ali, H., Stein, A. S., Yacoub, A., Rizzieri, D. A., Vasu, S., Gupta, V., Lee, S., Schiller, G. J., Foran, J. M., Taparia, M. S., Rosenblat, T. L., Walter, R. B., Sieminski, D., Anant, M., … Konopleva, M. (2021). Integrated Safety Analysis of Tagraxofusp, a CD123-Directed Targeted Therapy, in Patients with Hematologic Malignancies. Blood, 138(Supplement 1), 2318–2318. https://doi.org/10.1182/blood-2021-145344
Authors:
Naveen Pemmaraju
Hagop M. Kantarjian
Kendra Sweet
Eunice S. Wang
Andrew A. Lane
Haris Ali
Anthony S. Stein
Abdulraheem Yacoub
David A. Rizzieri
Sumithira Vasu
Vikas Gupta
Sang‐Min Lee
Gary J. Schiller
James M. Foran
Minakshi Taparia
Todd Rosenblat
Roland B. Walter
Debra Sieminski
Madhu Anant
Mrinal M. Patnaik
Tariq I. Mughal
Marina Konopleva
Affiliated Authors:
Todd Rosenblat
Columbia Affiliation:
Subjects:
Acute Myeloid Leukemia (OpenAlex Topic)
Genomic Aberrations and Treatment of Chronic Lymphocytic Leukemia (OpenAlex Topic)
Epidemiology and Treatment of Childhood Leukemia (OpenAlex Topic)
elink
Publication Type:
Article
Unique ID:
10.1182/blood-2021-145344
DOI:
10.1182/blood-2021-145344
Journal:
Blood
Publication Date:
Data Source:
OpenAlex
Source Link:
View OpenAlex Record

Record Created: